Collegium Pharmaceutical's total assets for Q3 2024 were $1.64B, an increase of 55.23% from the previous quarter. COLL total liabilities were $1.40B for the fiscal quarter, a 67.41% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.